Circulation, Vol 71, 487-494, Copyright © 1985 by American Heart Association
ML Greenberg, BF Uretsky, PS Reddy, RL Bernstein, BP Griffith, RL Hardesty, ME Thompson and HT Bahnson
To evaluate the long-term hemodynamic results in cardiac transplant
patients treated with cyclosporine and prednisone, 19 patients were studied
by cardiac catheterization and endomyocardial biopsy 13 +/- 3 months after
transplantation. Immunosuppression consisted of 6 +/- 4 mg/kg/day
cyclosporine and 20 +/- 8 mg/day prednisone. Eighteen patients were
asymptomatic but had developed postoperative systemic hypertension (17 on
antihypertensive therapy). These patients were compared with a normotensive
control group of 18 patients without cardiovascular disease. Significant
differences were found in heart rate; right atrial, pulmonary arterial,
pulmonary arterial wedge, systemic arterial, and left ventricular
end-diastolic pressures; cardiac index and stroke volume index; systemic
and pulmonary vascular resistance; and end-diastolic volume index and left
ventricular ejection fraction. The most frequent hemodynamic abnormalities
included an elevated arterial pressure in 10 patients (56%), an elevated
left ventricular end-diastolic pressure in six patients (33%), and a
reduced ejection fraction in five patients (28%). Hemodynamic abnormalities
tended to resolve or improve in the five patients restudied 2 years after
transplantation. There was no significant relationship between fibrosis or
inflammation on endomyocardial biopsy and hemodynamic abnormalities. We
conclude that mild-to-moderate hemodynamic abnormalities are common in
asymptomatic cardiac transplant patients receiving cyclosporine and
prednisone.
ARTICLES
Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone
This article has been cited by other articles:
![]() |
G McDowell, M Cave, A Bainbridge, M Danton, C Shaw, K.D Buchanan, J Wallwork, S Large, and D.P Nicholls Is the secretion of atrial natriuretic peptide in man under neural control? Eur. Heart J., March 2, 2000; 21(6): 498 - 503. [Abstract] [PDF] |
||||
![]() |
M. J. Carvalho, A. H. van den Meiracker, F. Boomsma, J. Freitas, A. J. Man in `t Veld, O. Costa, and A. F. de Freitas Role of Sympathetic Nervous System in Cyclosporine-Induced Rise in Blood Pressure Hypertension, July 1, 1999; 34(1): 102 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Armstrong, P. F. Binkley, P. B. Baker, P. D. Myerowitz, and C. V. Leier Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation J. Am. Coll. Cardiol., September 1, 1998; 32(3): 704 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lamich, M. Ballester, V. Marti, V. Brossa, R. Aymat, I. Carrio, L. Berna, M. Camprecios, M. Puig, M. Estorch, et al. Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation J. Am. Coll. Cardiol., August 1, 1998; 32(2): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |